Sanofi has an age limit of 65 for its CEO. Mr. Brandicourt will turn 65 in February 2021.
The drugmaker has been working on a “succession plan for some time now, in agreement and consultation with our CEO,” a company spokesperson told Reuters.
Mr. Brandicourt was hired in 2015 to help reshape Sanofi, which was facing intense pricing pressure from its diabetes unit and a thin pipeline of new drug candidates. Soon after taking the helm he unveiled a restructuring plan to cut costs and jobs.
Under his leadership, Sanofi sold its animal health unit to Boehringer Ingelheim and acquired the German firm’s consumer healthcare operations in a $20 billion deal. It also sold off its European generics unit.
Read the full report here.
More articles on pharmacy:
Harvard gets $100M infusion for drug research from hedge fund
Purdue Pharma CEO: Bankruptcy is ‘an option’ amid lawsuits
Intermountain CEO Dr. Marc Harrison: How Civica Rx will disrupt the drug industry
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.